Health

Assistive Reproductive Technology Market Forecast, Revenue, Demand, Growth and Key Companies Valuation by 2028

September 8, 2021

The global assisted reproductive technology market is projected to be worth USD 50.32 Billion by 2027, according to a new report by Emergen Research. The report provides Assistive Reproductive Technology market forecast, supported by detailed insights historical data and revenues, past and current market trends, industry trends, consumer trends, market size, market share, market growth, along with ranging impacts of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2024–2028. The report includes profiles of major players in the market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.The market for assisted reproductive technology (ART) is experiencing rapid growth attributed to the surging popularity of in-vitro fertilization (IVF) (with or without Intracytoplasmic Sperm Injection (ICSI)) and artificial insemination-intrauterine (AI-IUI), among other technologies.

Download FREE Sample Brochure (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/165

Global Assistive Reproductive Technology market forecast has been provided following thorough study, focus, comparison, and analysis of a varying range of factors and past market forecast and present outcomes. Assistive Reproductive Technology Market forecast is made possible through, but has not been limited to, a study and analysis of a variety of factors and trends, and these are verified through interviews with industry experts and companies operating in the market. The growing prevalence of ovulation problems, a common cause of infertility in women with irregular or no periods, is a significant factor driving the growth of the assisted reproductive technology market and accounts for around 25.0% of infertility cases in women across the globe. Rising focus by major companies on product/service expansion into new and untapped domestic markets, increasing investments in strategic agreements, favourable government policies and regulations, and growing competition in the market are some major trends observed in the Assistive Reproductive Technology market. Development of more advanced offerings is driving rising demand and deployment in respective sectors/industries, and this is expected to drive Assistive Reproductive Technology market revenue growth to a significant extent over the forecast period.

Browse Full Report Description with TOC@ https://www.emergenresearch.com/industry-report/assistive-reproductive-technology-market

Emergen Research has segmented the global assisted reproductive technology market on the basis of procedure, technology, end-users, and region:

Procedure Outlook (Revenue, USD Billion; 2017-2027)
- Fresh Donor
- Fresh Non-Donor
- Frozen Donor
- Frozen Non-Donor
- Egg/Embryo Banking

Technology Outlook (Revenue, USD Billion; 2017-2027)
- In-Vitro Fertilization (IVF)
  1. In-Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI)
  2. In-Vitro Fertilization (IVF) without Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination-Intrauterine (AI-IUI)
- Frozen Embryo Transfer (FET)
- Others

End-Users Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals
- Fertility Clinics
- Others

Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
  1. U.S.
  2. Canada
  3. Mexico
- Europe
  1. Germany
  2. UK
  3. France
  4. BENELUX
  5. Rest of Europe
- Asia Pacific
  1. China
  2. Japan
  3. South Korea
  4. Rest of APAC
- Latin America
  1. Brazil
  2. Rest of LATAM
- MEA
  1. Saudi Arabia
  2. UAE
  3. Rest of MEA

Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “Assistive Reproductive Technology Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2024 – 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain.

Key Highlights From The Report

In June 2024, Ferring Pharmaceuticals made an announcement about signing a two-year agreement with Igenomix for researching innovative disease mechanisms and targets discovery in conditions associated with infertility and pregnancy, such as preeclampsia, for developing groundbreaking diagnostic and therapeutic approaches in catering to unmet demand.
Frozen non-donor eggs are projected to grow at the fastest rate in the period 2024-2027, owing to their established reliability and a higher success rate for pregnancy.
Artificial Insemination-Intrauterine doesn’t require the removal of eggs from the body, and hence the procedure is far less invasive for the women who would conceive. Also, the process is cost-effective compared to IVF, as it doesn’t require egg extraction/laboratory monitoring.
The factors comprising well-resourced operating & surgical rooms, the presence of highly skilled healthcare professionals, higher purchasing power, and enhanced health coverage for healthcare services from various plans for private and group insurance, among others, are driving the demand for assisted reproductive technology in hospital. However, a decreased adoption of latest and innovative up-gradation is responsible for a lower market share.
Europe, led by France, Germany, and the UK, contributed to the largest assisted reproductive technology market share in 2019 attributed to growing novelties in clinical practice and improved fertility treatment access in the region. Also, the region is the first to remove the ‘experimental’ tag on cryopreservation of eggs.
Key participants include Origio, Cryolab Ltd., Bloom IVF Center, Ferring Pharmaceuticals, Cosmos Biomedical, Irvine Scientific, European Sperm Bank, Ovascience, Parallabs, and Microm UK Ltd., among others.

Request customized copy of Assistive Reproductive Technology report@ https://www.emergenresearch.com/request-for-customization/165

Region wise performance of the Assistive Reproductive Technology industry

North America Assistive Reproductive Technology market forecast is expected to remain significantly positive in terms of revenue share between 2024 and 2028. In addition, North America Assistive Reproductive Technology market revenue share is expected to remain comparatively larger than that of other regional markets from 2024 to 2028.

Asia Pacific registered fastest revenue CAGR in 2024, and the Assistive Reproductive Technology market forecast is that this trend is expected to continue going ahead. Market forecast states that revenue share contribution from China, India, and South Korea is expected to remain robust till 2028.

Europe Assistive Reproductive Technology market forecast is positive currently, with revenue growth expected to remain steady between 2024 and 2028. Robust focus on research and development initiatives by major firms and changing trends and demographics in countries in the region are some factors expected to continue to support Assistive Reproductive Technology market growth.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Table of Content

Chapter 1. Methodology & Sources

1.1. Assistive Reproductive Technology Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Assistive Reproductive Technology Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2024-2028

Chapter 3. Key Insights

Chapter 4. Assistive Reproductive Technology Market Segmentation & Impact Analysis

4.1. Assistive Reproductive Technology Market Material Segmentation Analysis

4.2. Industrial Outlook

4.2.1. Assistive Reproductive Technology Market indicators analysis

4.2.2. Assistive Reproductive Technology Market drivers analysis

4.2.2.1. Rapid urbanization and industrialization

4.2.2.2. Stringent government regulations regarding carbon emissions

4.2.2.3. Increasing prevalence of respiratory diseases

4.2.2.4. Rising need to enhance indoor air quality

4.2.3. Assistive Reproductive Technology Market restraints analysis

4.2.3.1. High cost associated with the maintenance of Assistive Reproductive Technology products

4.2.3.2. Availability of renewable sources of energy

4.3. Technological Insights

4.4. Regulatory Framework

4.5. Porter’s Five Forces Analysis

4.6. Competitive Metric Space Analysis

4.7. Price trend Analysis

4.8. Covid-19 Impact Analysis

Chapter 10. Competitive Landscape

10.1. Assistive Reproductive Technology Market Revenue Share By Manufacturers

10.2. Mergers & Acquisitions

10.3. Competitor’s Positioning

10.4. Strategy Benchmarking

10.5. Vendor Landscape

10.5.1. Raw Material Suppliers

10.5.1.1. North America

10.5.1.2. Europe

10.5.1.3. Asia Pacific

10.5.1.4. Middle East & Africa

10.5.1.5. Latin America

10.5.2. Distributors

10.5.2.1. North America

10.5.2.2. Europe

10.5.2.3. Asia Pacific

10.5.2.4. Middle East & Africa

10.5.2.5. Latin America

10.5.3. Others

Continued….

Avail Discount on Assistive Reproductive Technology Market Report@ https://www.emergenresearch.com/request-discount/165

The research provides answers to the following key questions:

What will be the growth rate and the market size of the Assistive Reproductive Technology industry for the forecast period 2024-2027?
What are the major driving forces expected to impact the development of the Assistive Reproductive Technology market across different regions?
Who are the major driving forces expected to decide the fate of the Assistive Reproductive Technology industry worldwide?
Who are the prominent market players making a mark in the Assistive Reproductive Technology market with their winning strategies?
Which Assistive Reproductive Technology industry trends are likely to shape the future of the industry during the forecast period 2024-2027?
What are the key barriers and threats believed to hinder the development of the industry?
What are the future opportunities in the Assistive Reproductive Technology market?

Why Choose Emergen Research?